Assessing the vulnerability of tourist destinations to overtourism: An empirical approach
Tourism Economics · 2026-03 · 32 (2) · 489-496
DOI: 10.1177/13548166251349240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tourism Economics, online erschienen am 11.06.2025. Verfasst von Angela Stefania Bergantino und 2 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union Next-GenerationEU.
Abstract (Originalsprache)
Overtourism is a complex issue affecting destinations in various ways. This study identifies the main causes and presents a framework using eight indicators related to transportation, accommodation, cultural and natural resources, and economic factors. Focusing on EU Mediterranean regions, the research applies this methodology at the municipal level in an Italian region with high seasonal tourist traffic. The findings highlight overtourism risk indicators, detailing the economic impact of tourism and destination vulnerabilities, and emphasize the need to rethink tourism growth models for better balance between local community welfare and visitor satisfaction.
Förderung
- European Union Next-GenerationEU
Zitieren
APA
Bergantino, A. S., Buongiorno, A., & Intini, M. (2026). Assessing the vulnerability of tourist destinations to overtourism: An empirical approach. Tourism Economics, 32(2), 489-496. https://doi.org/10.1177/13548166251349240
Vancouver
Bergantino AS, Buongiorno A, Intini M. Assessing the vulnerability of tourist destinations to overtourism: An empirical approach. Tourism Economics. 2026;32(2):489-496. doi:10.1177/13548166251349240
BibTeX
@article{Bergantino2026,
author = {Bergantino, Angela Stefania and Buongiorno, Alessandro and Intini, Mario},
title = {Assessing the vulnerability of tourist destinations to overtourism: An empirical approach},
journal = {Tourism Economics},
year = {2026},
volume = {32},
number = {2},
pages = {489--496},
doi = {10.1177/13548166251349240}
}
EUVIMED